Financial Summary
January 1, 2019 - December 31, 2019
First Quarter
January 1, 2019 - December 31, 2019
First Quarter
IR Events
Update on KHK4083: A phase 1 study in subjects with atopic dermatitis
December 3, 2018
On-demand replay (audio) will be available from Dec. 6, 2018 to Dec. 5, 2019.
Update on burosumab (KRN23): Clinical and regulatory updates, and pre-launch activities in the US and EU
October 27, 2017
IR News
-
May 13, 2019
Transcript of Results Presentation Fiscal 2019 First Quarter (including Q&A)
-
May 08, 2019
Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2019 First Quarter
（420KB）
-
May 08, 2019
Consolidated Financial Summary (IFRS) Fiscal 2019 First Quarter
（204KB）
-
April 24, 2019
Notice Concerning Completion of Consolidated Subsidiary Share Transfer
（223KB）
-
April 19, 2019
Annual Report 2018
